Integrating Artificial Intelligence and Nanotechnology for Precision Cancer Medicine

Artificial intelligence (AI) and nanotechnology are two fields that are instrumental in realizing the goal of precision medicine-tailoring the best treatment for each cancer patient. Recent conversion between these two fields is enabling better patient data acquisition and improved design of nanomaterials for precision cancer medicine. Diagnostic nanomaterials are used to assemble a patient-specific disease profile, which is then leveraged, through a set of therapeutic nanotechnologies, to improve the treatment outcome. However, high intratumor and interpatient heterogeneities make the rational design of diagnostic and therapeutic platforms, and analysis of their output, extremely difficult. Integration of AI approaches can bridge this gap, using pattern analysis and classification algorithms for improved diagnostic and therapeutic accuracy. Nanomedicine design also benefits from the application of AI, by optimizing material properties according to predicted interactions with the target drug, biological fluids, immune system, vasculature, and cell membranes, all affecting therapeutic efficacy. Here, fundamental concepts in AI are described and the contributions and promise of nanotechnology coupled with AI to the future of precision cancer medicine are reviewed.

[1]  Daniel Anderson,et al.  Delivery materials for siRNA therapeutics. , 2013, Nature materials.

[2]  Xiaoyuan Chen,et al.  Stimuli-Responsive Programmed Specific Targeting in Nanomedicine. , 2016, ACS nano.

[3]  Ulrike Tisch,et al.  A nanomaterial-based breath test for short-term follow-up after lung tumor resection. , 2013, Nanomedicine : nanotechnology, biology, and medicine.

[4]  Ladan Parhamifar,et al.  Remote‐loading of liposomes with manganese‐52 and in vivo evaluation of the stabilities of 52Mn‐DOTA and 64Cu‐DOTA using radiolabelled liposomes and PET imaging , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[5]  Patrick Couvreur,et al.  Stimuli-responsive nanocarriers for drug delivery. , 2013, Nature materials.

[6]  Xiaohua Huang,et al.  Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles. , 2006, Cancer letters.

[7]  Anne E Carpenter,et al.  Opportunities and obstacles for deep learning in biology and medicine , 2017, bioRxiv.

[8]  Gabriel A Kwong,et al.  Point-of-care diagnostics for noncommunicable diseases using synthetic urinary biomarkers and paper microfluidics , 2014, Proceedings of the National Academy of Sciences.

[9]  Jinming Gao,et al.  Theranostic nanomedicine for cancer. , 2008, Nanomedicine.

[10]  Vladimir Torchilin,et al.  Tumor delivery of macromolecular drugs based on the EPR effect. , 2011, Advanced drug delivery reviews.

[11]  Theresa M Reineke,et al.  Theranostics: combining imaging and therapy. , 2011, Bioconjugate chemistry.

[12]  F. Collins,et al.  A new initiative on precision medicine. , 2015, The New England journal of medicine.

[13]  Molly M Stevens,et al.  Enzyme-responsive nanoparticles for drug release and diagnostics. , 2012, Advanced drug delivery reviews.

[14]  Julio Saez-Rodriguez,et al.  Machine Learning Prediction of Cancer Cell Sensitivity to Drugs Based on Genomic and Chemical Properties , 2012, PloS one.

[15]  Jin Kon Kim,et al.  Electrically actuatable smart nanoporous membrane for pulsatile drug release. , 2011, Nano letters.

[16]  Robert Langer,et al.  Multiparametric approach for the evaluation of lipid nanoparticles for siRNA delivery , 2013, Proceedings of the National Academy of Sciences.

[17]  Hao Cheng,et al.  Hyaluronidase Embedded in Nanocarrier PEG Shell for Enhanced Tumor Penetration and Highly Efficient Antitumor Efficacy. , 2016, Nano letters.

[18]  P. A. Futreal,et al.  Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. , 2012, The New England journal of medicine.

[19]  J. Lieberman,et al.  A modular platform for targeted RNAi therapeutics , 2018, Nature Nanotechnology.

[20]  Amiram Goldblum,et al.  Computer-aided design of liposomal drugs: In silico prediction and experimental validation of drug candidates for liposomal remote loading. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[21]  Gang Liu,et al.  High-sensitivity nanosensors for biomarker detection. , 2012, Chemical Society reviews.

[22]  Zulfiqur Ali,et al.  Data analysis for electronic nose systems , 2006 .

[23]  Philip S Low,et al.  Folate-mediated delivery of macromolecular anticancer therapeutic agents. , 2002, Advanced drug delivery reviews.

[24]  Daniel C. Zielinski,et al.  Personalized Whole-Cell Kinetic Models of Metabolism for Discovery in Genomics and Pharmacodynamics. , 2015, Cell systems.

[25]  H. Yeh,et al.  Single-quantum-dot-based DNA nanosensor , 2005, Nature materials.

[26]  Erica R Thaler,et al.  In Vitro Discrimination of Tumor Cell Lines with an Electronic Nose , 2005, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[27]  Harikrishna Narasimhan,et al.  Predicting clinical response to anticancer drugs using an ex vivo platform that captures tumour heterogeneity , 2015, Nature Communications.

[28]  Daniel G. Anderson,et al.  Molecularly Self-Assembled Nucleic Acid Nanoparticles for Targeted In Vivo siRNA Delivery , 2012, Nature nanotechnology.

[29]  Neetu Singh,et al.  Nanoparticles that communicate in vivo to amplify tumour targeting. , 2011, Nature materials.

[30]  N. D. de Rooij,et al.  Label-free detection of single protein molecules and protein-protein interactions using synthetic nanopores. , 2008, Analytical chemistry.

[31]  C. Borrebaeck.  Precision diagnostics: moving towards protein biomarker signatures of clinical utility in cancer , 2017, Nature Reviews Cancer.

[32]  N. Svrzikapa,et al.  First-in-humans trial of an RNA interference therapeutic targeting VEGF and KSP in cancer patients with liver involvement. , 2013, Cancer discovery.

[33]  A. Cheng,et al.  CRISPR-Cas9-mediated multiplex gene editing in CAR-T cells , 2016, Cell Research.

[34]  D. Longo,et al.  Tumor heterogeneity and personalized medicine. , 2012, The New England journal of medicine.

[35]  Bela Molnar,et al.  DNA methylation biomarkers for blood-based colorectal cancer screening. , 2008, Clinical chemistry.

[36]  K. G. Rajeev,et al.  Rational design of cationic lipids for siRNA delivery , 2010, Nature Biotechnology.

[37]  David Sept,et al.  Real-time shape approximation and fingerprinting of single proteins using a nanopore. , 2015, Nature nanotechnology.

[38]  T. Porter,et al.  Thermosensitive liposomes for localized delivery and triggered release of chemotherapy. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[39]  P. Gupta.  Single-molecule DNA sequencing technologies for future genomics research. , 2008, Trends in biotechnology.

[40]  Bernd Jagla,et al.  Sequence characteristics of functional siRNAs. , 2005, RNA.

[41]  Jerzy Leszczynski,et al.  Using nano-QSAR to predict the cytotoxicity of metal oxide nanoparticles. , 2011, Nature nanotechnology.

[42]  S. Turner,et al.  Real-time DNA sequencing from single polymerase molecules. , 2010, Methods in enzymology.

[43]  Masateru Taniguchi,et al.  Decoding DNA, RNA and peptides with quantum tunnelling. , 2016, Nature nanotechnology.

[44]  S. Maerkl,et al.  LSPR chip for parallel, rapid, and sensitive detection of cancer markers in serum. , 2014, Nano letters.

[45]  Zhen Gao,et al.  Predict drug permeability to blood‐brain‐barrier from clinical phenotypes: drug side effects and drug indications , 2016, Bioinform..

[46]  L. Brannon-Peppas,et al.  Nanoparticle and targeted systems for cancer therapy. , 2004, Advanced drug delivery reviews.

[47]  Ashley M. Laughney,et al.  Predicting therapeutic nanomedicine efficacy using a companion magnetic resonance imaging nanoparticle , 2015, Science Translational Medicine.

[48]  Onofrio Resta,et al.  An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD. , 2009, Lung cancer.

[49]  David A. Matthews,et al.  Real-time, portable genome sequencing for Ebola surveillance , 2016, Nature.

[50]  Stuart Lindsay,et al.  The promises and challenges of solid-state sequencing. , 2016, Nature nanotechnology.

[51]  Sergey Shityakov,et al.  In silico models for nanotoxicity evaluation and prediction at the blood-brain barrier level: A mini-review , 2017 .

[52]  Jin Liu,et al.  Computational model for nanocarrier binding to endothelium validated using in vivo, in vitro, and atomic force microscopy experiments , 2010, Proceedings of the National Academy of Sciences.

[53]  R Berbeco,et al.  The use of theranostic gadolinium-based nanoprobes to improve radiotherapy efficacy , 2014, The British journal of radiology.

[54]  Burghardt Wittig,et al.  Novel optical nanosensors for probing and imaging live cells. , 2010, Nanomedicine : nanotechnology, biology, and medicine.

[55]  Casey S. Greene,et al.  Unsupervised Feature Construction and Knowledge Extraction from Genome-Wide Assays of Breast Cancer with Denoising Autoencoders , 2014, Pacific Symposium on Biocomputing.

[56]  M. Jeffery,et al.  Fraction size in radiation treatment for breast conservation in early breast cancer. , 2008, The Cochrane database of systematic reviews.

[57]  H. Troy Nagle,et al.  Performance of the Levenberg–Marquardt neural network training method in electronic nose applications , 2005 .

[58]  D. Peer,et al.  RNAi-based nanomedicines for targeted personalized therapy. , 2012, Advanced drug delivery reviews.

[59]  D. Chan,et al.  The Road from Discovery to Clinical Diagnostics: Lessons Learned from the First FDA-Cleared In Vitro Diagnostic Multivariate Index Assay of Proteomic Biomarkers , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[60]  M. Yigit,et al.  Simultaneous detection of circulating oncomiRs from body fluids for prostate cancer staging using nanographene oxide. , 2014, ACS applied materials & interfaces.

[61]  David Tamborero,et al.  OncodriveROLE classifies cancer driver genes in loss of function and activating mode of action , 2014, Bioinform..

[62]  Yongyi Yang,et al.  Machine Learning in Medical Imaging , 2010, IEEE Signal Processing Magazine.

[63]  Alison Stopeck,et al.  Circulating tumor cells, disease progression, and survival in metastatic breast cancer. , 2004, The New England journal of medicine.

[64]  M. Saeb,et al.  Modeling and closed-loop control of particle size and initial burst of PLGA biodegradable nanoparticles for targeted drug delivery , 2017 .

[65]  E. Lander,et al.  Development and Applications of CRISPR-Cas9 for Genome Engineering , 2014, Cell.

[66]  Michael P. Schroeder,et al.  In silico prescription of anticancer drugs to cohorts of 28 tumor types reveals targeting opportunities. , 2015, Cancer cell.

[67]  Daniel G. Anderson,et al.  Semi-automated synthesis and screening of a large library of degradable cationic polymers for gene delivery. , 2003, Angewandte Chemie.

[68]  N. McGranahan,et al.  Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future , 2017, Cell.

[69]  Hugo Y. K. Lam,et al.  Personal Omics Profiling Reveals Dynamic Molecular and Medical Phenotypes , 2012, Cell.

[70]  Ahmed Hosny,et al.  Artificial intelligence in radiology , 2018, Nature Reviews Cancer.

[71]  L. Trizio,et al.  Exhaled volatile organic compounds identify patients with colorectal cancer , 2013, The British journal of surgery.

[72]  Shana O Kelley,et al.  Beyond the Capture of Circulating Tumor Cells: Next-Generation Devices and Materials. , 2016, Angewandte Chemie.

[73]  Mark E. Davis,et al.  Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles , 2010, Nature.

[74]  V. Rotello,et al.  Rapid phenotyping of cancer stem cells using multichannel nanosensor arrays. , 2018, Nanomedicine : nanotechnology, biology, and medicine.

[75]  N. Aluru,et al.  DNA base detection using a single-layer MoS2. , 2014, ACS nano.

[76]  Rebecca Richards-Kortum,et al.  Plasmonic nanosensors for imaging intracellular biomarkers in live cells. , 2007, Nano letters.

[77]  Muhammad A. Alam,et al.  Performance limits of nanobiosensors , 2006 .

[78]  B. Luo,et al.  Prediction of siRNA knockdown efficiency using artificial neural network models. , 2005, Biochemical and biophysical research communications.

[79]  M. Calleja,et al.  Detection of cancer biomarkers in serum using a hybrid mechanical and optoplasmonic nanosensor. , 2014, Nature nanotechnology.

[80]  David J. Mooney,et al.  Active scaffolds for on-demand drug and cell delivery , 2010, Proceedings of the National Academy of Sciences.

[81]  Yinhua Yu,et al.  Potential markers that complement expression of CA125 in epithelial ovarian cancer. , 2005, Gynecologic oncology.

[82]  Colin D. Medley,et al.  Molecular engineering of DNA: molecular beacons. , 2009, Angewandte Chemie.

[83]  S. Lindsay,et al.  Single Molecule Spectroscopy of Amino Acids and Peptides by Recognition Tunneling , 2014, Nature nanotechnology.

[84]  Pieter Wesseling,et al.  RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics , 2015, Cancer cell.

[85]  R. Cataneo,et al.  Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study , 1999, The Lancet.

[86]  Assaf Zinger,et al.  Theranostic barcoded nanoparticles for personalized cancer medicine , 2016, Nature Communications.

[87]  S. Turner,et al.  Real-Time DNA Sequencing from Single Polymerase Molecules , 2009, Science.

[88]  Zhanwen Xing,et al.  Gold-nanoshelled microcapsules: a theranostic agent for ultrasound contrast imaging and photothermal therapy. , 2011, Angewandte Chemie.

[89]  Daniel G. Anderson,et al.  Knocking down barriers: advances in siRNA delivery , 2009, Nature Reviews Drug Discovery.

[90]  Qing Zhao,et al.  Boron Nitride Nanopores: Highly Sensitive DNA Single‐Molecule Detectors , 2013, Advanced materials.

[91]  E Gabrielson,et al.  Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[92]  Omid C Farokhzad,et al.  pH-Responsive nanoparticles for drug delivery. , 2010, Molecular pharmaceutics.

[93]  Gengfeng Zheng,et al.  Multiplexed electrical detection of cancer markers with nanowire sensor arrays , 2005, Nature Biotechnology.

[94]  Scott A. Beatson,et al.  Tracking antibiotic resistance , 2014, Science.

[95]  T. Tuschl,et al.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells , 2001, Nature.

[96]  Tyson A. Clark,et al.  Direct detection of DNA methylation during single-molecule, real-time sequencing , 2010, Nature Methods.

[97]  Sam Emaminejad,et al.  Fully integrated wearable sensor arrays for multiplexed in situ perspiration analysis , 2016, Nature.

[98]  A. Zaniboni,et al.  Anti-EGFR therapy in colorectal cancer: how to choose the right patient. , 2009, Current drug targets.

[99]  Hossam Haick,et al.  Self-Healable Sensors Based Nanoparticles for Detecting Physiological Markers via Skin and Breath: Toward Disease Prevention via Wearable Devices. , 2016, Nano letters.

[100]  K. Kataoka,et al.  Recent progress in development of siRNA delivery vehicles for cancer therapy. , 2016, Advanced drug delivery reviews.

[101]  Kinam Park,et al.  Targeted drug delivery to tumors: myths, reality and possibility. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[102]  R. Sinclair,et al.  Multiplex detection of protease activity with quantum dot nanosensors prepared by intein-mediated specific bioconjugation. , 2008, Analytical Chemistry.

[103]  H. Haick,et al.  Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors , 2010, British Journal of Cancer.

[104]  A. Metwally,et al.  Towards better modelling of drug-loading in solid lipid nanoparticles: Molecular dynamics, docking experiments and Gaussian Processes machine learning. , 2016, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[105]  Jan Grimm,et al.  Nanoparticles for imaging: top or flop? , 2014, Radiology.

[106]  Hugh E. Olsen,et al.  The Oxford Nanopore MinION: delivery of nanopore sequencing to the genomics community , 2016, Genome Biology.

[107]  F. Franconi,et al.  Pharmacogenomics, pharmacokinetics and pharmacodynamics: interaction with biological differences between men and women , 2014, British journal of pharmacology.

[108]  R. Vile,et al.  Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[109]  John D. Chodera,et al.  Quantitative Self-Assembly Prediction Yields Targeted Nanomedicines , 2017, Nature Materials.

[110]  S. Hussain,et al.  Robust long-read native DNA sequencing using the ONT , 2020 .

[111]  C. Dekker.  Solid-state nanopores. , 2007, Nature nanotechnology.

[112]  F. Kiessling,et al.  The theranostic path to personalized nanomedicine , 2014, Clinical and translational imaging.

[113]  P. Kantoff,et al.  Cancer nanomedicine: progress, challenges and opportunities , 2016, Nature Reviews Cancer.

[114]  Michael Bittner,et al.  Pilot study using molecular profiling of patients' tumors to find potential targets and select treatments for their refractory cancers. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[115]  H. Haick,et al.  Diagnosing lung cancer in exhaled breath using gold nanoparticles. , 2009, Nature nanotechnology.

[116]  M. Eblan,et al.  Clinical Translation of Nanomedicine. , 2015, Chemical reviews.

[117]  Daniel G. Anderson,et al.  Silencing or stimulation? siRNA delivery and the immune system. , 2011, Annual review of chemical and biomolecular engineering.

[118]  Yu-qiang Ma,et al.  Designing nanoparticle translocation through membranes by computer simulations. , 2012, ACS nano.

[119]  Dan Peer,et al.  Progress and challenges towards targeted delivery of cancer therapeutics , 2018, Nature Communications.

[120]  C. Dekker,et al.  DNA sequencing with nanopores , 2012, Nature Biotechnology.

[121]  Martin Fritts,et al.  Nanoinformatics: a new area of research in nanomedicine , 2012, International journal of nanomedicine.

[122]  Jianping Fu,et al.  Supplementary Information for Multiplex Serum Cytokine Immunoassay Using Nanoplasmonic Biosensor Microarrays , 2015 .

[123]  R. Jain,et al.  Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology. , 2013, Cancer research.

[124]  Dimitrios I. Fotiadis,et al.  Machine learning applications in cancer prognosis and prediction , 2014, Computational and structural biotechnology journal.

[125]  A. Ullrich,et al.  Paul Ehrlich's magic bullet concept: 100 years of progress , 2008, Nature Reviews Cancer.

[126]  Mathieu Foquet,et al.  Improved fabrication of zero-mode waveguides for single-molecule detection , 2008 .

[127]  S. Hussain,et al.  Robust long-read native DNA sequencing using the ONT CsgG Nanopore system , 2017, Wellcome open research.

[128]  Antony K. Chen,et al.  Superparamagnetic Iron Oxide Nanoparticle Probes for Molecular Imaging , 2006, Annals of Biomedical Engineering.

[129]  D. Branton,et al.  Characterization of individual polynucleotide molecules using a membrane channel. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[130]  X. Qu,et al.  Near‐Infrared Light‐Triggered, Targeted Drug Delivery to Cancer Cells by Aptamer Gated Nanovehicles , 2012, Advanced materials.

[131]  Jin He,et al.  Identifying single bases in a DNA oligomer with electron tunnelling. , 2010, Nature nanotechnology.

[132]  Wolfgang A. Weber,et al.  Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging , 2007, Proceedings of the National Academy of Sciences.

[133]  Bin Wang,et al.  Artificial sensing intelligence with silicon nanowires for ultraselective detection in the gas phase. , 2014, Nano letters.

[134]  A. Fire,et al.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans , 1998, Nature.

[135]  Hiroshi Maeda,et al.  Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity. , 2015, Advanced drug delivery reviews.

[136]  María Vallet-Regí,et al.  Polymer-Grafted Mesoporous Silica Nanoparticles as Ultrasound-Responsive Drug Carriers. , 2015, ACS nano.

[137]  Stefano Alcaro,et al.  Design and Development of Biomimetic Nanovesicles Using a Microfluidic Approach , 2018, Advanced materials.

[138]  Daniel R. Garalde,et al.  Highly parallel direct RNA sequencing on an array of nanopores , 2016, Nature Methods.

[139]  Shan X Wang,et al.  nanoLAB: an ultraportable, handheld diagnostic laboratory for global health. , 2011, Lab on a chip.

[140]  Sanghamitra Chatterjee,et al.  Nanomaterials based electrochemical sensors for biomedical applications. , 2013, Chemical Society reviews.

[141]  Andrew S. Peek,et al.  Improving model predictions for RNA interference activities that use support vector machine regression by combining and filtering features , 2007, BMC Bioinformatics.

[142]  Roberto Molinaro,et al.  Bio-inspired engineering of cell- and virus-like nanoparticles for drug delivery. , 2017, Biomaterials.

[143]  M. Niederweis,et al.  Reading DNA at single-nucleotide resolution with a mutant MspA nanopore and phi29 DNA polymerase , 2012, Nature Biotechnology.

[144]  Jinming Gao,et al.  Modeling particle shape-dependent dynamics in nanomedicine. , 2011, Journal of nanoscience and nanotechnology.

[145]  Gilmer Valdes,et al.  Clinical decision support of radiotherapy treatment planning: A data-driven machine learning strategy for patient-specific dosimetric decision making. , 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[146]  Robert N Grass,et al.  Covalently functionalized cobalt nanoparticles as a platform for magnetic separations in organic synthesis. , 2007, Angewandte Chemie.

[147]  Eric T. Wang,et al.  Barcoded nanoparticles for high throughput in vivo discovery of targeted therapeutics , 2017, Proceedings of the National Academy of Sciences.

[148]  Joseph Kost,et al.  Ultrasound triggered release of cisplatin from liposomes in murine tumors. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[149]  Charles M. Lieber,et al.  Direct ultrasensitive electrical detection of DNA and DNA sequence variations using nanowire nanosensors , 2004 .

[150]  Hong-ming Ding,et al.  Theoretical and computational investigations of nanoparticle-biomembrane interactions in cellular delivery. , 2015, Small.

[151]  N. Schork.  Personalized medicine: Time for one-person trials , 2015, Nature.

[152]  J. Ross,et al.  Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[153]  Ke Xu,et al.  Effect of Cell Sex on Uptake of Nanoparticles: The Overlooked Factor at the Nanobio Interface. , 2018, ACS nano.

[154]  Gang Liu,et al.  PEGylated WS2 Nanosheets as a Multifunctional Theranostic Agent for in vivo Dual‐Modal CT/Photoacoustic Imaging Guided Photothermal Therapy , 2014, Advanced materials.

[155]  Jun Ge,et al.  Drug release from electric-field-responsive nanoparticles. , 2012, ACS nano.

[156]  Lang Yi,et al.  CRISPR-Cas9 therapeutics in cancer: promising strategies and present challenges. , 2016, Biochimica et biophysica acta.

[157]  M. Machluf,et al.  Nanoghosts as a Novel Natural Nonviral Gene Delivery Platform Safely Targeting Multiple Cancers. , 2016, Nano letters.

[158]  H. Haick,et al.  Sensors for breath testing: from nanomaterials to comprehensive disease detection. , 2014, Accounts of chemical research.

[159]  P. Cullis,et al.  Lipid Nanoparticles Enabling Gene Therapies: From Concepts to Clinical Utility. , 2018, Nucleic acid therapeutics.

[160]  Vincent Gau,et al.  Oral Fluid Nanosensor Test (OFNASET) with Advanced Electrochemical‐Based Molecular Analysis Platform , 2007, Annals of the New York Academy of Sciences.

[161]  Chad A Mirkin,et al.  Exploration of the nanomedicine-design space with high-throughput screening and machine learning , 2019, Nature Biomedical Engineering.

[162]  Shuming Nie,et al.  Peptide-linked molecular beacons for efficient delivery and rapid mRNA detection in living cells. , 2004, Nucleic acids research.

[163]  Mark E. Davis,et al.  Pharmacokinetics and tumor dynamics of the nanoparticle IT-101 from PET imaging and tumor histological measurements , 2009, Proceedings of the National Academy of Sciences.

[164]  Alphus D. Wilson,et al.  Applications and Advances in Electronic-Nose Technologies , 2009, Sensors.

[165]  Luonan Chen,et al.  ellipsoidFN: a tool for identifying a heterogeneous set of cancer biomarkers based on gene expressions , 2012, Nucleic acids research.

[166]  Audrey Lee-Gosselin,et al.  Acoustic reporter genes for noninvasive imaging of microbes in mammalian hosts , 2017, Nature.

[167]  C. Fan,et al.  Ultrasensitive, multiplexed detection of cancer biomarkers directly in serum by using a quantum dot-based microfluidic protein chip. , 2010, ACS nano.

[168]  Robert Langer,et al.  A combinatorial library of lipid-like materials for delivery of RNAi therapeutics , 2008, Nature Biotechnology.

[169]  B. Bettencourt,et al.  Safety and efficacy of RNAi therapy for transthyretin amyloidosis. , 2013, The New England journal of medicine.

[170]  Sara Goodwin,et al.  Oxford Nanopore sequencing, hybrid error correction, and de novo assembly of a eukaryotic genome , 2015, bioRxiv.

[171]  Rongsheng E. Wang,et al.  A homogeneous fluorescent sensor for human serum albumin. , 2012, Journal of pharmaceutical and biomedical analysis.

[172]  L. Joshi,et al.  Glycosylation-Based Serum Biomarkers for Cancer Diagnostics and Prognostics , 2015, BioMed research international.

[173]  Ilias Tagkopoulos,et al.  Multi-omics integration accurately predicts cellular state in unexplored conditions for Escherichia coli , 2016, Nature Communications.

[174]  E. Fung,et al.  Ovarian malignancy risk stratification of the adnexal mass using a multivariate index assay. , 2013, Gynecologic oncology.